Topical Glucocorticoid-Induced Cushing’s Syndrome in a Patient with Erythrodermic Psoriasis: A Case Report
This case highlights the systemic risks of unsupervised, escalating use of high-potency topical corticosteroids in adults with impaired skin barrier. It underscores the need for adherence to dosing guidelines, patient education, and routine endocrine monitoring.
Authors
- Ge Qin (ORCID: https://orcid.org/0009-0007-2810-2358)
- Gen Quan
- Xing Peng (ORCID: https://orcid.org/0000-0002-5099-781X)
- Xiaodong She (ORCID: https://orcid.org/0000-0002-8719-0462)
- Jingjing Wu (ORCID: https://orcid.org/0000-0002-7164-0764)
Institutions
- Wuhan University (CN)
- First People’s Hospital of Jingmen (CN)
- Wuhan Asia Heart Hospital (CN)
- Wuhan General Hospital of Guangzhou (CN)
Publication Details
- Journal
- Clinical Cosmetic and Investigational Dermatology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/ccid.s540407
- Citations
- 1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.80